UTHSCSA - Faculty Profiles

Search All | Profile | Publications | Grants | Faculty Index

Peters, Jay I

School of Medicine
Medicine
(210) 617-5256
peters@uthscsa.edu

Appointments Education Expertise Teaching Publications Grants

9/2018 - Present	Chair Clinical Emergency Response Committee (CERC)	South Texas Veterans Health Care System, San Antonio, TX
4/2009 - Present	Chief, Division of Pulmonary and Critical Care Medicine	University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX
1/2009 - Present	Adjunct Professor Pharmaceutics	University of Texas at Austin, Pharmacology, Austin, TX
9/1996 - Present	Chair, Cold Blue Committee	South Texas Veterans Health Care System, Medicine, San Antonio, TX
9/1996 - Present	ACLS Instructor	South Texas Veterans Healthcare System, San Antonio, TX
9/1996 - Present	Professor	The University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX
9/1994 - Present	Medical Director	University of Texas Health Science Center at San Antonio, Department of Respiratory Therapy, San Antonio, TX
8/1994 - Present	Medical Director	School of Allied Health, San Antonio, TX
6/1984 - Present	Staff Physician and Staff Physician	The South Texas Veterans Healthcare System, Audie L Murphy Division, Pulmonary Diseases and Critical Care, San Antonio, TX
6/1984 - Present	Assistant Foundation Scientist	Southwest Foundation for Biomedical Research, San Antonio, TX

Date	Description	Institution	# Students
11/2013 - Present	Grand Rounds - Asthma 2013:Pathogenesis, Therapies and Controversies	North Shore LIJ	100 students

1/2012 - Present	Pre-Doctoral Student Supervision	University of Texas at Austin

1/2012 - Present	Pre-Doctoral Student Supervision	University of Texas at Austin

9/2008 - Present	Dilemma`s in the ICU	University of Texas Health Science Center at San Antonio	50 students
Medical School Ethics Presentation
7/2006 - Present	Special Topic	The University of Texas Health Science Center
Bronchoscopy Attending 8-12 weeks/year, 10 hours/week
7/2006 - Present	Adv Clin Eval Skills	The University of Texas Health Science Center

6/2006 - Present	Internal Medicine Morning Report	University of Texas Health Science Center at San Antonio	50 students
Faculty discussion for daily intern and resident morning conference.
1/2006 - Present	Pre-Doctoral Student Supervision	University of Texas at Austin College of Pharmacy/UTHSCSA

10/2001 - Present	RESC3025 Critical Respiratory
Course Director - I teach the respiratory therapy students who are part of the DA on master's program.A variety of topics such as 1. trouble shooting the ventilator, 2. systematic steps to safely extubate patients, 3. management of acute respiratory failure, 4. management of stridor and acute laryngela edema, 5. bilevel positive airway pressure, among other topics
10/2001 - Present	Management of Severe Asthma		45 students
Guidelines for Medicine Residents
8/2001 - Present	Adv Physical Diagnosis	The University of Texas Health Science Center
Annual Pulmonary ACES course: Pre clinical teaching using patients with a variety of pulmonary diseases (i.e. very severe chronic obstructive pulmonary disease, pulmonary fibrosis, and/or post lung transplant) to emphasize physical exam techniques that emphasize the identification and diagnosis of pulmonary problems. After significant encouragement and requests from the students.
7/2001 - Present	Post Graduate Rotation Supervision	UTHSCSA/ VA/UHS

4/2001 - Present	Physician Lecture Series for Respiratory Therapists		45 students
Annual or bi-annual interactive lectures on respiratory and intensive care unit (ICU) topics such as chronic obstructive pulmonary disease, percutaneous tracheostomy, sedations in the ICU, weaning from mechanical ventilations, chest radiography, status asthmaticus.
1/2001 - Present	Management of Shock		40 students
Guidelines for Medicine. Annual, interactive, case-based lecture
7/2000 - Present	Intro to Clin Medicine	The University of Texas Health Science Center
Annual Pulmonary ACES Course: Pre-clinical teaching using patients with a variety of pulmonary diseases (i.e., very severe chronic obstructive pulmonary disease, pulmonary fibrosis, and/or post-lung transplant) to emphasize physical exam techniques that emphasize the identification and diagnosis of pulmonary problems.
9/1996 - Present	Post-Doctoral Student Supervision	University of Texas Health Science Center at San Antonio

9/1994 - Present	Post-Doctoral Student Supervision	University of Texas Health Science Center at San Antonio

9/1993 - Present	Post-Doctoral Student Supervision	University of Texas Health Science Center at San Antonio

9/1992 - Present	Post-Doctoral Student Supervision	University of Texas Health Science Center at San Antonio

9/1988 - Present	Post-Doctoral Student Supervision	University of Texas Health Science Center at San Antonio

9/1988 - Present	Post-Doctoral Student Supervision	University of Texas Health Science Center at San Antonio

9/1985 - Present	Post-Doctoral Student Supervision	University of Texas Health Science Center at San Antonio

9/1984 - Present	Post-Doctoral Student Supervision	University of Texas Health Science Center at San Antonio

7/1984 - Present	Clinical Medicine	The University of Texas Health Science Center	20 students

7/1984 - Present	Clinical Medicine II	The University of Texas Health Science Center	10 students
South Texas Veterans Healthcare System, Pulmonary Clinic Attending: 1/2 day clinic per week for 16 weeks, 5-6 contact hours per week.
7/1984 - Present	Off Campus	The University of Texas Health Science Center	10 students
Medicine Thoracic Clinic Attending, University Hospital-Downtown: 1/2 day clinic per week, 6-8 weeks, 5-6 contact hours/week.

Abstract

Peters JI. Non-Human primate model of non-tuberculous mycobacteria (NTM) Pulmonary Disease; 2019 Oct.

Peters JI. The effectiveness of the mistyox high fraction of inspired oxygen(FIO2)- High flow nebulizer and the thera mist air entrainment nebulizer in delivering high oxygen concentrations; 2019 Oct.

Peters JI. How reliable are the asthma links most commonly share on Twitter?; 2019 Oct.

Singh H, Peters JI, Yogeet Kaur, Maselli DJ, Diaz JD. Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach. The real-life effectivenes of omalizumab therapy (reality)study: Elsevier; 2019 Aug. (Annal of Allergy Asthma Immunolo).

Peters JI, Maselli DJ. Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation o fexacerbations, emergency department visits, lung function, and oral corticosteroid use; 2018 Oct. (Ther Clin Risk Manag).

Restrepo MI. Intratracheal Administration of Mesenchymal Stem Cells Improves survival in a mouse model of severe pneumococcal pneumonia; 2017 May. (American Thoracic Society International Conference).

Estrada RA, Maselli DJ, Peters JI. Severe Dyspnea: A bone of Contention. American Thoracic Society Annual Meeting Washington, DC: American Thoracic Society; 2017 May. (ATS Annual Meeting).

Peters JI. Callithrix jacchus: a non-human primate model of mycobacterium avium complex pulmonary infection?; 2017 May.

Peters JI. Pleuran Fluid pH: Comparing analytical methods and the Impact on clinical decision making; 2017 May.

N.A. Hanania, S. S Braman, J. Ohar, Adams SG, A. Ari, S. Sanjar, J. Brooks, Peters JI, D.A. Mahler, Adewuya. Exploring Health Care Providers` Practice Gaps in Prescribing Inhalation Delivery Devices for the Management of COPD. Resultos from the Delivery Makes a Difference (DMaD) Survey: SUNOVION; 2017 Jan. (CHEST).

Amalakuhan Bravein, King Phoebe C, Peters JI, Malave AJ. "Itching from the Skin to the Lungs: case of Varicella pneumonia ?; 2015 Oct. (Chest).

Sha Liu, Allan B. Watts, Ju Du, Amanda Bui, Soraya Hengsawas, Peters JI, Robert O. Williams III. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery; 2015 Jul. (Eur J Pharm Biopharm).

Peters JI. Improved Inhaled Combination therapies through particle engineerin; 2015 Jan. (Chest Journal).

Susanto IS, Sako EY, Anzueto AR, Levine SM, Peters JI, Cronin T, Jenkinson SG, Bryan C. Outcome of single lung transplants from the same donor: "Pulmonary Twinning"; 1995 Oct. (Chest; vol. 108, no. 3).

Book Chapter

Shelledy DC, Peters JI. Patient History (Chapter 4). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones and Bartlett; 2022. p. 87-136.

Peters JI, Shelledy D. Introductions to Critical Respiratory Care. In: Peters JI, Shelledy D. Mechanical Ventilation. 2019. p. 1-27.

Peters JI, Shelledy D. Ventilator Initiation. In: Peters JI, Shelledy D. Mechanical Ventilation. 2019. p. 311-364.

Peters JI, Shelledy D. Patient Stabilization:Adjusting Ventilatory Support. In: Peters JI, Shelledy D. Mechanical Ventilation. 2019. p. 367-394.

Peters JI, Shelledy D. Indications for Mechanical Ventilation. In: Peters JI, Shelledy D. Mechanical Ventilation. 2019. p. 281-309.

Peters JI, Proud KC, Shelledy D. Ventilator Discontinuance. In: Peters JI, Proud KC, Shelledy D. Mechanical Ventilation. 2019. p. 637-575.

Peters JI, Shelledy D. Respiratory Failure. In: Peters JI, Shelledy D. Mechanical Ventilation. 2019. p. 27-92.

Peters J, Levine S, Velez M. Introduction to Pulmonary Function Testing. In: Edited by J.T. DiPiro, R.L. Talber, G.C. Yee, G.R. Matzke, B.G. Wells, L. M. Posey. Pharmacotherapy: A Pathophysiology Approach. 2016. p. 455-462.

Book/Monograph

Shelledy D, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development 2022.

David Shelledy Jay Peters Kevin Proud (consulting editor). Mechanical Ventilation United States: Burlington, MA : Jones & Bartlett Learning; 2019.

Editorial

Peters JI. Pooled RCT: Adding LABAs to ICS do not increase serious asthma events and reduce exacerbations Annal of Inter Med 2018 Oct;.

Peters JI. Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations Annal of Inter Med 2018 Jun;168(12).

Mangat M, Amalakuhan B, Habib, Sheila, Reyes, LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto AR, Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, Witzenrath M, Waterer G, Martin Loceches, Blanquer J, Sanz F, Marcos PJ, Sole-Violan, Chalmers JD, Feldman C, Wunderink RG, Cruz CSD, Orijuela CJ, Restrepo MI. High Endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis Eur Respir J 2017 Jul;50(1):1-4.

Peters JI. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthma Annal of Inter Med 2015 Jun;.

Electronic/Web Publication

Peters JI. Macrolides for Severe Asthma 2017 Jul.

Peters JI. E-cigarettes 2017 Jul. Available from: https://foundation.chestnet.org/e-cigarettes/ .

Peters JI. Smoking and Tobacco Use 2017 Jan. Available from: https://foundation.chestnet.org/patient-education-resources/smoking/ .

Peters JI. COPD: American Lung Association/American College of Chest Physicians 2016 Jun.

Peters JI. Pulmonary Arterial Hypertension: American Lung Association/American College of Chest Physicians 2016 Jun.

Peters JI. Asthma: American Lung Association/American College of Chest Physicians 2016 May.

Peters JI. Sarcoidosis: American Lung Association/American College of Chest Physicians 2016 May.

Journal Article

Peters JI. In spontaneous pneumothorax, initial needle aspiration and large- and narrow-bore chest tubes do not differ for success Annals of Intern med 2020 Jul;.

Peters JI, Maselli DJ. Chronic Asthma and risk of cardiovascular disease 2020 Mar;.

Peters JI. COVID 19 in a Hispanic Woman: Autopsy Report with Clinical Pathological Correlation Archive of Path & Lab Med 2020 Jan;.

Peters JI, Maselli DJ, Megan Hardin, Stephanie Christenson, Nicola Hanania, Craig Hearsh, Adams SG, Anzueto AR, Meilan Han, Fernando Martinez. Clinical Approach to the Therapy of Ashtma-COPD Overlap Chest Journal 2019 Jan;:168-177.

Proud KC, Maselli DJ, Peters JI. The lung mucosa environment in the elderly increases host susceptibility to Mycobacterium tuberculosis infection Journal of Infectious disease 2019 Jan;.

Peters JI. Pooled RCTs: Adding LABAs to ICS do not increase serious asthma events and reduce exacerbations ACP Journal Club 2018 Oct;.

Peters JI, Maselli DJ. Medication Regimens for Managing Acute Asthma Respir Care 2018 Jun;63(6):783-796.

Nicola Hanania, Sidney Braman, Adams SG, Ruth Adewuya, Arzu Ari, JoAnn Brooks, Donald Mahler, Jill Ohar, Peters JI, Shanhin Sanjar. The Role of Inhalatin Delivery Devices in COPD: Perspectives of patients and health care providers Journal of the COPD Foundation 2018 Jan;5(2).

Peters JI, Maselli DJ. Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations N engl J Med 2018 Jan;378:902-910.

Das NA, Peters JI, Jeremy D. Simmons, Yibo Wang, Kevin P. O`Donnell, DeArmond DT, Coalson JJ, Brooks EG, Johnson SB. The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model The Journal of Thoracic and Cardiovascular Surgery 2017 Dec;154(6):2144-2151.

Fernandez-Restrepo L, Shaffer L, Amalakuhan B, Restrepo MI, Peters JI, Restrepo RD. Effects of intrapulmonary percussive ventilation on airway mucus clearance: a bench model World Journal of Critical Care Medicine 2017 Oct;.

Maselli DJ, Peters JI. In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months Annals of Internal Medicine 2017 Oct;.

Maselli DJ, Medina JL, Brooks EG, Coalson JJ, Kannan TR, Winter VT, Principe M, Cagle MP, Baseman JB, Dube PH, Peters JI. The immunopathologic effects of Mycoplasma pneumoniae and CARDS toxin: a primate model Am J Respir Cell Mol Bio 2017 Sep;.

Pamela Wood, MD; Jordan C Kampschmidt, BS; Peter H Dube, PhD; Marianna P Cagle, MA; Paola Chaparro, MS; Norma Ketchum; Thirumalai R Kannan, PhD; Harjinder Singh, MD; Jay I Peters, MD; Joel B Baseman, PhD; Edward G Brooks, MD. Mycoplasma pneumoniae and health outcomes in children with asthma Annals of Allergy, Asthma & Immunology 2017 Aug;.

Peters JI. Oral Glucocorticoid-sparing effect of benralizumab in severe asthma American College Physician Journal Club 2017 Jul;.

Nambiar AM, Anzueto AR, Peters JI. Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis PLoS One 2017 Apr;12(4).

Peters JI. Attenuation of lung and tumor fibrosis by fibroblast-specific inhibition of TGFB1 signaling Journal of Clinical Investigation 2017 Jan;.

Jorge Villalpando, Peters JI, Adams SG. Inducible laryngeal obstruction/vocal cord dysfunction and the role it plays in refractory asthma Arch Asthma Allergy Immunol 2017 Jan;.

Julien Maincent, Laura K. Najvar, William R. Kirkpatrick, Siyuan Huang, Thomas F. Patterson, Nathan P. Wiederhold, Peters JI, Robert O. Williams III. Modified Release Itraconazole Amorphous Solid Dispersion to Treat Aspergillus fumigatus: Importance of the Animal Model Selection. (In Press) Drug Development and Industrial Pharmacy 2016 Sep;.

Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and Management of Sarcoidosis Am Fam Physician 2016 May;93(10):840-848.

Maselli DJ, Peters JI. ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide Annals of Internal Medicine 2016 Jan;164(2):6-6.

Peters JI. Iatrogenic Endobronchial bleeding: speed things up or cool it down? Interventional Pulmonology 2015 Jul;22(3):191-194.

Maselli DJ, Peters JI. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthma Annals of Internal Medicine 2015 Jun;162(12):5-5.

Maselli DJ, Adams SG, Peters JI, Levine SM. Management of asthma during pregnancy Therapeutic Advances in Respiratory Diseases 2013 Apr;7(2):87-100.

Peters JI, Singh, H., Brooks EG, Diaz, J., Kannan TR, Coalson JJ, Baseman, J, Cagle, M., Baseman JB. Persistence of Community-Acquired Respiratory Distress Syndrome Toxin-Producing Mycoplasma pneumoniae in Refractory Asthma Chest 2011 Aug;140(2):401-407.

Hardy, RD, Coalson JJ, Peters, JI, Chaparro, A, Techasaensiri, C, Cantwell AM, Kannan TR, Baseman JB, Dube PH. Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin Public Library of Science (PLoS ONE) 2009 Oct;4(10).

Not Specified

Peters JI. A case of Mycobacterium simiae mimicking malignancy Inter J Pulm & Res sci 2018 Mar;2(5):001-002.

Peters JI. Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection Industrial Pharmacy 2017 Feb;.

Peters JI. Adding tiotropium to ICSs alone or with LABAS improves pulmonary function in asthma Annals of Internal Medicine 2015 Jun;.

Other

Bayer, J, Das NA, Baisden CE, Rani M, Schwacha MG, Sako EY, Williams, RO, Peters JI, Johnson SB. Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model 93rd Annual Meeting of The American Association for Thoracic Surgery 2013 May;146(5).

Review Article

Tuangrat, Praphawatvet, Peters JI, Robert O William. Inhaled nanoparticles- An updated review Inter Jour of Pharmaceutics 2020 May;.

Federal
Funding Agency	NIH
Title	Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status	Active
Period	9/2007 - Present
Role	Co-Investigator
Grant Detail	Genetic Epidemiology of Chronic Obstructive Pulmonary Disease. The original local grant was approximately $1.2 million. Renewal - 7/1/2017-7/31/2018
Private
Funding Agency	Merrell-Dow
Title	Use of Deflazocort in Chronic Asthma
Status	Active
Period	10/1990 - Present
Role	Principal Investigator
Grant Detail
Funding Agency	Wilford Foundation
Title	Creation of a Marmoset Model of Mycobacterium Avium Complex
Status	Active
Period	6/2015 - 6/2019
Role	Co-Investigator
Grant Detail	Develop a primate model of non tuberculous mycobacterial (NTM) pulmonary diseases
Funding Agency	Lung Therapeutics/UT School of Pharmacy
Title	Development of Inhaled Tacrolimus Nanoparticles in Acute Lung Injury
Status	Active
Period	6/2017 - 6/2019
Role	Co-Investigator
Grant Detail	This grant uses thin film freezing to create nanoparticles that are delivered in the form of brittle matrix that dispense to both large/small airways and the alveolar surface. Patents belong to UT Health San Antonio/UT School of Pharmacy.
Funding Agency	UT Health at San Antonio Med/Pulmonary Diseases Divisional Funds
Title	Mycoplasma Pneumoniae Infection in Patients with Chronic Asthma - Data Analysis
Status	Active
Period	11/2017 - 11/2018
Role	Co-Investigator
Grant Detail	Data analysis of research data compiled from Dr. Joel Baseman`s NIH grant, Role of unique ADP-ribosylating vaculolating Mycoplasma penumoniae toxin in asthma, Grant Number: U19AI070412

Funding Agency	Gates Foundation
Title	Role of Alveolar Macrophage Function in Tuberculosis
Status	Active
Period	7/2017 - Present
Role	Principal Investigator
Grant Detail	Major goals: Obtain blood monocytes and alveolar macrophages from healthy volunteers for the Texas BioMedical Research Institute to study their role in prevention and resolution of infection from M. tuberculosis

Year	Degree	Discipline	Institution
1983	Postdoctoral Fellowship	Pulmonary/Critical Care/Infectious Disease (Pulmonary/Critical Care/Infectious Disease Fellowship)	Baylor College of Medicine Houston , TX
1980	Postdoctoral Fellowship	Internship and Residency (Infectious Diseases)	Baylor College of Medicine Houston , TX
1980	Residency	Chief Medical Resident (Chief Medical Resident, 7/80 - 12/80)	Baylor College of Medicine Houston , TX
1976	MD	Medicine (Alpha Omega Alpha)	Baylor College of Medicine Houston , TX
1973	BA	(Magna Cum Laude)	University of Texas at Austin Austin , TX
1970	BA	(Honors & Scholars Program)	Tulane University New Orleans , LA

Faculty

FAQ

Suggestions